Dr. Charpentier, the 2016 laureate, proposes to address the multifaceted immune activation on several fronts concomitantly, with an approach suitable to develop an immunity-focused line of research within the group, taking advantage of the extraordinary expertise in microbiology available.  

Prof. Tausku Honjo, the 2014 laureate, decided to dedicate his grand funds to the launch of “Improvement of PD-1(Programmed Death Cell Protein-1) Antibody Cancer Immunotherapy,” a cancer-fighting research project.

Dr. James P. Allison, the 2014 laureate, decides to use his grand fund to set up a fellowship program for junior researchers in the field of cancer immunotherapy.